510(k) Summary
FEB 2 4 2005
General Information | - :
R050 2323
Classification Class If —_—
Trade Name Coaxial Introducer
Submitter Vivant Medical, Inc.
1916-A Old Middlefield Way
Mountain View, CA 94043
(650) 694-2900
Contact Kristine Foss
Vice President, Regulatory, Quality and Clinical
Intended Use
The VivaWave™ Microwave Ablation System is intended for coagulation of soft tissue. The
Coaxial Introducer is intended to aid insertion of the microwave energy applicator component of the
system. The system is not intended for use in cardiac procedures.
Predicate Devices
VivaWave™ Microwave Ablation System KO11676
Device Description
The VivaWave™ Microwave Ablation System consists of a microwave power generator and a
disposable probe that is the microwave energy applicator. The disposable probe is inserted into
soft tissue to coagulate a volume of tissue surrounding the active area of the probe. The Coaxial
Introducer may be used to aid insertion of the microwave energy applicator.
Materials
All patient contact materials used in the manufacture of the Coaxial Introducer are suitable for
this use and have been used in numerous previously cleared products.
Summary of Substantial Equivalence
The VivaWave Microwave Ablation System with the addition of the Coaxial Introducer is
equivalent to the predicate products. The indications for use, basic overall function, methods of
manufacturing, and materials used are substantially equivalent. Vivant Medical believes the
Coaxial Introducer is substantially equivalent to existing legally marketed devices.
13

ee
f & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
a _ —— —_—$ $$ $$ $<
Food and Drug Administration
9 9200 Corporate Boulevard
FEB 2 4 2005 Rockville MD 20850
Ms. Kristine Foss
Vice President, Regulatory, Quality and Clinical
Vivant Medical, Inc.
1916-A Old Middlefield Way
Mountain View, California 94043
Re: K050223
Trade/Device Name: Coaxial Introducer
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: II
Product Code: GEI
Dated: January 28, 2005
Received: February 9, 2005 ‘
Dear Ms. Foss:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
- for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. TT he
gencral controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I (Special Controls) or class II (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination docs not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administcred by other Federal agencies. You must
comply with all the Act’s requirements, including. but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801), good manufacturing practice requirements as sel
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Kristine Foss
This letter will allow you to begin marketing your device as described in your Section 5] 0(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
“Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/industry/support/index. html.

Sincerely yours,

— Mruian C overt
[a . .
é Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

Indications for Use
510(k) Number (if known): This application kK Oo 5a 2232 3
Device Name: Coaxial Introducer
Indications for Use: The VivaWave™ Microwave Ablation System is
intended for coagulation of soft tissue. The Coaxial
Introducer is intended to aid insertion of the microwave
energy applicator component of the system. The system
is not intended for use in cardiac procedures.
Prescription Use xX OR Over-The-Counter Use
(Per 21 CFR 801.109) (Optional Format 1-2-96)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
proton (Port
(Division Sign-Off)
Division of Geveral, Restorative,
and Neurological Devices
K6 50343
§10(k) Number.) = <2 .
12

